Trade Valneva SE - VLA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.018641% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.003582% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | France | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.75 |
| Open | 3.76 |
| 1-Year Change | 14.63% |
| Day's Range | 3.59 - 3.76 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 3.69 | -0.08 | -2.12% | 3.77 | 3.78 | 3.52 |
| Feb 20, 2025 | 3.75 | 0.13 | 3.59% | 3.62 | 3.80 | 3.56 |
| Feb 19, 2025 | 3.63 | 0.04 | 1.11% | 3.59 | 3.73 | 3.44 |
| Feb 18, 2025 | 3.56 | 0.18 | 5.33% | 3.38 | 3.61 | 3.35 |
| Feb 17, 2025 | 3.35 | 0.16 | 5.02% | 3.19 | 3.41 | 3.14 |
| Feb 14, 2025 | 3.31 | -0.36 | -9.81% | 3.67 | 3.73 | 3.16 |
| Feb 13, 2025 | 3.67 | -0.23 | -5.90% | 3.90 | 3.95 | 3.49 |
| Feb 12, 2025 | 3.92 | 0.13 | 3.43% | 3.79 | 4.21 | 3.59 |
| Feb 11, 2025 | 3.61 | 0.22 | 6.49% | 3.39 | 3.68 | 3.34 |
| Feb 10, 2025 | 3.28 | 0.08 | 2.50% | 3.20 | 3.49 | 3.17 |
| Feb 7, 2025 | 3.12 | -0.21 | -6.31% | 3.33 | 3.33 | 3.09 |
| Feb 6, 2025 | 3.28 | 0.13 | 4.13% | 3.15 | 3.44 | 3.09 |
| Feb 5, 2025 | 3.08 | 0.33 | 12.00% | 2.75 | 3.12 | 2.68 |
| Feb 4, 2025 | 2.64 | 0.02 | 0.76% | 2.62 | 2.71 | 2.55 |
| Feb 3, 2025 | 2.67 | 0.02 | 0.75% | 2.65 | 2.71 | 2.55 |
| Jan 31, 2025 | 2.72 | 0.16 | 6.25% | 2.56 | 2.80 | 2.52 |
| Jan 30, 2025 | 2.40 | 0.09 | 3.90% | 2.31 | 2.45 | 2.29 |
| Jan 29, 2025 | 2.35 | 0.04 | 1.73% | 2.31 | 2.43 | 2.26 |
| Jan 28, 2025 | 2.28 | 0.09 | 4.11% | 2.19 | 2.31 | 2.16 |
| Jan 27, 2025 | 2.23 | 0.04 | 1.83% | 2.19 | 2.27 | 2.18 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Valneva SE Company profile
About Valneva SE
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.
Financial summary
BRIEF: For the six months ended 30 June 2021, Valneva SE revenues decreased 1% to EUR47.5M. Net loss applicable to common stockholders increased from EUR25.6M to EUR86.4M. Revenues reflect Commercialized Vaccines segment decrease of 22% to EUR31.8M, Canada segment decrease of 75% to EUR2M, United Kingdom segment decrease of 75% to EUR1.1M, Europe excluding France segment decrease of 42% to EUR4.2M.
Equity composition
07/2010, Rights Issue, 2 new shares for every 5 shares held @ EUR 5.06 (Factor: 1.12817). 6/2013, Rights Issue, 5 new shares for every 13 shares held @ EUR2.65 (Factor: 1.11881). 1/2015, Rights Issue, 11 new shares for every 34 shares held @ EUR2.47 (Factor: 1.10896).
| Industry: | Biotechnology & Medical Research (NEC) |
6 rue Alain Bombard
SAINT-HERBLAIN
PAYS DE LA LOIRE 44800
FR
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com